Skip to main content

Table 3 Patient-based analysis of detectable lesions prior (T1) and during ADT (T2)

From: [68Ga]Ga-PSMA-11 PET before and after initial long-term androgen deprivation in patients with newly diagnosed prostate cancer: a retrospective single-center study

Pat Prostatic lesions [n] Lymph node metastases [n] Bone metastases [n] T-stage miN-stage miM-stage Max_Score Summed score
T1 T2 T1 T2 T1 T2 T1/T2 T1 T2 T1 T2 T1 T2 T1 T2
1 1 1 7 2 3 2 T3 N1b N1b M1b M1b 3 2 23 6
2 2 1 4 1 4 1 T1 N1b N1a M1b M1b 3 3 21 7
3 1 1 7 0 5 2a T3 N1b N0 M1b M1b 2 2 21 4
4 1 1 10 7 1 0 T3 N1b N1b M1b M1a 3 3 27 18
5 1 1 1 1 2 1 T2 N1a N1a M1b M1b 2 2 5 4
6 1 1 2 1 1 1 T2 N1b N1a M1b M1b 2 3 8 6
7 1 1 6 0 0 0 T3 N1b N0 M1a M0 3 2 15 2
8 1 0 0 0 3 1 T3 N0 N0 M1b M1b 2 0 6 0
9 1 1 1 0 0 0 T1 N0 N0 M1a M0 2 1 3 1
10 1 1 0 0 1 1 T3 N0 N0 M1b M1b 2 2 4 4
11 1 1 5 3 0 0 T3 N1b N1b M0 M0 3 2 16 6
12 1 0 1 0 2 0 T4 N1a N0 M1b M0 3 0 8 0
13 1 1 0 0 1 1 T1 N0 N0 M1b M1b 2 2 4 3
14 1 1 1 1 1 0 T3 N1a N1a M1b M0 2 1 6 2
15 1 1 1 0 0 0 T3 N1a N0 M0 M0 3 2 5 2
16 1 1 0 0 1 1 T2 N0 N0 M1b M1b 2 2 4 3
17 1 0 5 0 0 0 T1 N1b N0 M1a M0 2 0 8 0
18 1 1 3 2 1 0 T3 N1b N1b M1b M0 3 3 8 5
19 2 0 0 0 1 1 T3 N0 N0 M1b M1b 3 1 6 1
20 1 1 1 1 0 0 T3 N1a N1a M0 M0 3 2 5 3
21 2 2 1 1 0 0 T3 N1a N1a M0 M0 3 3 9 7
24 18 56 20 27 12       53 38 212 84
  1. aNew manifestation under ADT